ClinicalTrials.gg
Sign In

Leukemia, Basophilic, Acute clinical trials

The registry lists 55 studies for Leukemia, Basophilic, Acute across more than 10 countries. 0 are recruiting or about to start. 19 of them are mainly about Leukemia, Basophilic, Acute (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-21.

Status

Completed
41
Terminated
7
Status unknown
5
Active, not recruiting
2

Phase

Phase 1
22
Phase 2
20
Phase 3
7
Phase 4
1

Where

United States
42
Canada
6
Italy
4
Belgium
3
Netherlands
3
France
3

Who runs them

National Cancer Institute (NCI) (20) · SWOG Cancer Research Network (4) · Fred Hutchinson Cancer Center (3) · Alliance for Clinical Trials in Oncology (3) · Gruppo Italiano Malattie EMatologiche dell'Adulto (2) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2) · Roswell Park Cancer Institute (2) · Children's Oncology Group (2)

What is being tested here

Drugs under test in Leukemia, Basophilic, Acute studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cytarabine0113
Gemtuzumab045
Tipifarnib015
Daunorubicin014
Clofarabine004
Idarubicin004
Etoposide013
Eltrombopag002
Busulfan012
Imatinib002

Drug classes tested here Antimetabolites 18 · Alkylating agents 4 · Tyrosine kinase inhibitors (TKIs) 4

Who these studies take

No Leukemia, Basophilic, Acute study is recruiting now.

Across all 55 studies, recruiting or not: 36% stop at 75 or younger and 31% at 65; 31% take children; 2% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 55. Browse all 55 → or search them.